With the analysis among 102 patents, we discovered top 22 key players by total patent application. Resverlogix Corp., Nalpropion Pharmaceuticals LLC, Orexigen Therapeutics, Inc. are dominant in this area. They take 41.18% of the total patent filing.
Alberta, Canada
Patent: 15
California, United States
Patent: 12
Indiana, United States
Patent: 11
Cambridgeshire, United Kingdom
Patent: 7
Jiangsu Sheng, China
Patent: 7
New Jersey, United States
Patent: 4
California, United States
Patent: 4
New York, United States
Patent: 3
No data, please try another search term
With the analysis among related 46 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Resverlogix Corp., Eli Lilly & Co., Taipei Medical University take 63.04% of patent filing during this period.
Alberta, Canada
Patent: 15
Indiana, United States
Patent: 11
Taiwan Province, China
Patent: 3
Georgia, United States
Patent: 2
Illinois, United States
Patent: 2
California, United States
Patent: 2
Andhra Pradesh, India
Patent: 2
California, United States
Patent: 1
Basel-Stadt, Switzerland
Patent: 1
With the analysis among related 46 patents in last 5 years, we discover 10 new entrants. Resverlogix Corp., Eli Lilly & Co., Taipei Medical University are the most active new entrants in this area.
Alberta, Canada
Patent: 15
Indiana, United States
Patent: 11
Taiwan Province, China
Patent: 3
Georgia, United States
Patent: 2
Andhra Pradesh, India
Patent: 2
Illinois, United States
Patent: 2
California, United States
Patent: 1
undefined undefined
Patent: 1
Bimaikang Biomedical Technology (Guangzhou) Co., Ltd.
Guangdong Sheng, China
Patent: 1
Basel-Stadt, Switzerland
Patent: 1
With the analysis among 9 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Taiwan Province, China
Patent: 3
Georgia, United States
Patent: 2
Zhejiang Sheng, China
Patent: 2